Cell to cell interactions of human myeloma cells and BMMSCs or pre-OBs were shown to inhibit OB formation and function via blockade of Runx2 activity [147], which was accompanied by a diminished expression of OB differentiation markers (i.e., ALP, osteocalcin, and collagen I). The gene discussed is RUNX2; the disease is plasma cell myeloma.